NCT04347603View on ClinicalTrials.gov

Sedation or General Anesthesia During TAVR

NACompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

December 8, 2020

Primary Completion Date

March 20, 2024

Study Completion Date

March 20, 2024

Conditions
Stenoses, Aortic
Interventions
PROCEDURE

TAVR

Femoral percutaneous aortic prosthesis (TAVR)

Trial Locations (2)

Unknown

University hospital, Montpellier

University hospital, Nîmes

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04347603 - Sedation or General Anesthesia During TAVR | Biotech Hunter | Biotech Hunter